Peluang Kejadian Ototoksisitas pada Penggunaan Kanamisin dalam Pengobatan Tuberkulosis Resisten Obat Ganda Selama Satu Bulan

Ototoxic drugs are medicines that cause toxic reactions to structures in the cochlea, vestibule, semicircular canal, and otolith. Kanamycin is a drug used in the treatment of Multidrug Resistant Tuberculosis (MDR TB) and potentially ototoxic. This study aimed to determine the possibility of kanamyci...

Full description

Bibliographic Details
Main Authors: Lussie Rakhmawati, Ratna Anggraeni Agustian, Wijana
Format: Article
Language:English
Published: Universitas Padjajaran 2015-12-01
Series:Majalah Kedokteran Bandung
Subjects:
Online Access:http://journal.fk.unpad.ac.id/index.php/mkb/article/view/619
_version_ 1818527298520875008
author Lussie Rakhmawati
Ratna Anggraeni Agustian
Wijana
author_facet Lussie Rakhmawati
Ratna Anggraeni Agustian
Wijana
author_sort Lussie Rakhmawati
collection DOAJ
description Ototoxic drugs are medicines that cause toxic reactions to structures in the cochlea, vestibule, semicircular canal, and otolith. Kanamycin is a drug used in the treatment of Multidrug Resistant Tuberculosis (MDR TB) and potentially ototoxic. This study aimed to determine the possibility of kanamycin ototoxicity as an initial step of early detection in MDR TB treatment . This study was a descriptive study conducted prospectively and performed in dr. Hasan Sadikin General Hospital Bandung during the period of January–June 2014. The study involved MDR TB patients. Preliminary examinations were performed using pure tone audiometry, tympanometry and DPOAE, which was then followed by further investigations using DPOAE examination every 3 days during the first month of treatment. The results showed cochlear disorders on the right and left ear started to 10,000 Hz frequency on days 19–21, then the frequency of 8,000 Hz on days 25–27. There was a negative relationship between cochlear disorders due to use of kanamycin with age, and no correlation between cochlear disorders with gender and body mass index. In conclusion, possibility of kanamycin ototoxicity in patients with MDR TB begins at the end of the second week, first on high frequency and continues to lower frequency.
first_indexed 2024-12-11T06:34:19Z
format Article
id doaj.art-8e04bf5db7a041d0b35729be83430205
institution Directory Open Access Journal
issn 0126-074X
2338-6223
language English
last_indexed 2024-12-11T06:34:19Z
publishDate 2015-12-01
publisher Universitas Padjajaran
record_format Article
series Majalah Kedokteran Bandung
spelling doaj.art-8e04bf5db7a041d0b35729be834302052022-12-22T01:17:25ZengUniversitas PadjajaranMajalah Kedokteran Bandung0126-074X2338-62232015-12-0147422423010.15395/mkb.v47n4.619Peluang Kejadian Ototoksisitas pada Penggunaan Kanamisin dalam Pengobatan Tuberkulosis Resisten Obat Ganda Selama Satu BulanLussie Rakhmawati0Ratna Anggraeni Agustian1Wijana2Rumah Sakit Siloam Sriwijaya PalembangDepartemen Ilmu Kesehatan Telinga Hidung Tenggorok-Bedah Kepala Leher Fakultas Kedokteran Universitas Padjadjaran/Rumah Sakit Dr. Hasan Sadikin BandungDepartemen Ilmu Kesehatan Telinga Hidung Tenggorok-Bedah Kepala Leher Fakultas Kedokteran Universitas Padjadjaran/Rumah Sakit Dr. Hasan Sadikin BandungOtotoxic drugs are medicines that cause toxic reactions to structures in the cochlea, vestibule, semicircular canal, and otolith. Kanamycin is a drug used in the treatment of Multidrug Resistant Tuberculosis (MDR TB) and potentially ototoxic. This study aimed to determine the possibility of kanamycin ototoxicity as an initial step of early detection in MDR TB treatment . This study was a descriptive study conducted prospectively and performed in dr. Hasan Sadikin General Hospital Bandung during the period of January–June 2014. The study involved MDR TB patients. Preliminary examinations were performed using pure tone audiometry, tympanometry and DPOAE, which was then followed by further investigations using DPOAE examination every 3 days during the first month of treatment. The results showed cochlear disorders on the right and left ear started to 10,000 Hz frequency on days 19–21, then the frequency of 8,000 Hz on days 25–27. There was a negative relationship between cochlear disorders due to use of kanamycin with age, and no correlation between cochlear disorders with gender and body mass index. In conclusion, possibility of kanamycin ototoxicity in patients with MDR TB begins at the end of the second week, first on high frequency and continues to lower frequency.http://journal.fk.unpad.ac.id/index.php/mkb/article/view/619Early detectionMDR TBkanamycinototoxic
spellingShingle Lussie Rakhmawati
Ratna Anggraeni Agustian
Wijana
Peluang Kejadian Ototoksisitas pada Penggunaan Kanamisin dalam Pengobatan Tuberkulosis Resisten Obat Ganda Selama Satu Bulan
Majalah Kedokteran Bandung
Early detection
MDR TB
kanamycin
ototoxic
title Peluang Kejadian Ototoksisitas pada Penggunaan Kanamisin dalam Pengobatan Tuberkulosis Resisten Obat Ganda Selama Satu Bulan
title_full Peluang Kejadian Ototoksisitas pada Penggunaan Kanamisin dalam Pengobatan Tuberkulosis Resisten Obat Ganda Selama Satu Bulan
title_fullStr Peluang Kejadian Ototoksisitas pada Penggunaan Kanamisin dalam Pengobatan Tuberkulosis Resisten Obat Ganda Selama Satu Bulan
title_full_unstemmed Peluang Kejadian Ototoksisitas pada Penggunaan Kanamisin dalam Pengobatan Tuberkulosis Resisten Obat Ganda Selama Satu Bulan
title_short Peluang Kejadian Ototoksisitas pada Penggunaan Kanamisin dalam Pengobatan Tuberkulosis Resisten Obat Ganda Selama Satu Bulan
title_sort peluang kejadian ototoksisitas pada penggunaan kanamisin dalam pengobatan tuberkulosis resisten obat ganda selama satu bulan
topic Early detection
MDR TB
kanamycin
ototoxic
url http://journal.fk.unpad.ac.id/index.php/mkb/article/view/619
work_keys_str_mv AT lussierakhmawati peluangkejadianototoksisitaspadapenggunaankanamisindalampengobatantuberkulosisresistenobatgandaselamasatubulan
AT ratnaanggraeniagustian peluangkejadianototoksisitaspadapenggunaankanamisindalampengobatantuberkulosisresistenobatgandaselamasatubulan
AT wijana peluangkejadianototoksisitaspadapenggunaankanamisindalampengobatantuberkulosisresistenobatgandaselamasatubulan